BTIG Maintains Buy on Praxis Precision Medicine, Price Target $826
BTIG maintained its Buy rating on Praxis Precision Medicine's stock and set a price target of $826.00, implying a 191.3% upside from its previous close.
BTIG maintained its Buy rating on Praxis Precision Medicine's stock and set a price target of $826.00, implying a 191.3% upside from its previous close.